 SOLANA BEACH, Calif., Nov. 02, 2022 GLOBE NEWSWIRE -- Evoke Pharma, Inc. NASDAQ: EVOK, a specialty pharmaceutical company focused on treatments for gastrointestinal GI diseases, today announced that the Company is scheduled to release its third quarter on Wednesday, November 9, 2022, after the market closes. 